{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:10:33Z","timestamp":1778749833109,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["ZHYX202104"],"award-info":[{"award-number":["ZHYX202104"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.prp.2024.155717","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T18:30:39Z","timestamp":1731090639000},"page":"155717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["BCL11A expression worsens the prognosis of DLBCL and its co-expression with C-MYC predicts poor survival"],"prefix":"10.1016","volume":"264","author":[{"given":"Lixin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.prp.2024.155717_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11523-019-00662-4","article-title":"Inhibition of Aurora A kinase in combination with chemotherapy induces synthetic lethality and overcomes chemoresistance in myc-overexpressing lymphoma","volume":"14","author":"Park","year":"2019","journal-title":"Target Oncol."},{"issue":"3","key":"10.1016\/j.prp.2024.155717_bib2","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.prp.2024.155717_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/1541-7786.MCR-20-0466","article-title":"Aggressive B-cell lymphoma with MYC\/TP53 dual alterations displays distinct clinicopathobiological features and response to novel targeted agents","volume":"19","author":"Deng","year":"2021","journal-title":"Mol. Cancer Res"},{"issue":"1","key":"10.1016\/j.prp.2024.155717_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.prp.2024.155717_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-04906-8","article-title":"Super-enhancer hypermutation alters oncogene expression in B cell lymphoma","author":"Bal","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.prp.2024.155717_bib6","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190604","article-title":"BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases","volume":"39","author":"Yin","year":"2019","journal-title":"Biosci. Rep."},{"issue":"9","key":"10.1016\/j.prp.2024.155717_bib7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1056\/NEJMoa1103070","article-title":"A functional element necessary for fetal hemoglobin silencing[J]","volume":"365","author":"Sankaran","year":"2011","journal-title":"N. Engl. J. Med"},{"issue":"7577","key":"10.1016\/j.prp.2024.155717_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature15521","article-title":"BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis","volume":"527","author":"Canver","year":"2015","journal-title":"Nature"},{"issue":"33","key":"10.1016\/j.prp.2024.155717_bib9","doi-asserted-by":"crossref","first-page":"11707","DOI":"10.1074\/jbc.RA120.014018","article-title":"The transcriptional repressor BCL11A promotes breast cancer metastasis","volume":"295","author":"Seachrist","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prp.2024.155717_bib10","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1038\/s41467-018-05790-5","article-title":"BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous carcinoma","volume":"9","author":"Lazarus","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2024.155717_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-12-61","article-title":"BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification","volume":"12","author":"Jiang","year":"2013","journal-title":"Mol. Cancer"},{"issue":"13","key":"10.1016\/j.prp.2024.155717_bib12","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1084\/jem.20121846","article-title":"Bcl11a is essential for lymphoid development and negatively regulates p53","volume":"209","author":"Yu","year":"2012","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.prp.2024.155717_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00820","article-title":"BCL11A is oncogenic and predicts poor outcomes in natural killer\/T-cell lymphoma","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.prp.2024.155717_bib14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/cjp2.223","article-title":"c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma","volume":"7","author":"Bouroumeau","year":"2021","journal-title":"J. Pathol. Clin. Res"},{"issue":"7","key":"10.1016\/j.prp.2024.155717_bib15","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms[J]","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.prp.2024.155717_bib16","unstructured":"Ott G., Alaggio R., Dave S.S. et al, Large B-cell lymphomas, in: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours. Lyon (France): International Agency for Research on Cancer; 2024. (WHO classification of tumours series, 5th ed.; vol.11, pp. 461\u2013472.). https:\/\/publications.iarc.who.int\/637."},{"issue":"11","key":"10.1016\/j.prp.2024.155717_bib17","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.prp.2024.155717_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/PAS.0000000000000542","article-title":"High-grade B-cell lymphoma With MYC rearrangement and without BCL2 and BCL6 rearrangements is associated with high P53 expression and a poor prognosis","volume":"40","author":"Li","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"issue":"12","key":"10.1016\/j.prp.2024.155717_bib19","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/PAS.0000000000001577","article-title":"High-grade B-cell lymphoma with MYC, BCL2, and\/or BCL6 translocations\/rearrangements clinicopathologic features of 51 cases in a single institution of South China","volume":"44","author":"Zhang","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155717_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7054134","article-title":"The analysis of bcl-2 in association with p53 and Ki-67 in triple negative breast cancer and other molecular subtypes in Ghana","volume":"2021","author":"Ameh-Mensah","year":"2021","journal-title":"J. Oncol."},{"issue":"6058","key":"10.1016\/j.prp.2024.155717_bib21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.1211053","article-title":"Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing","volume":"334","author":"Xu","year":"2011","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.prp.2024.155717_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2029392","article-title":"Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease","volume":"384","author":"Esrick","year":"2021","journal-title":"N. Engl. J. Med"},{"issue":"6","key":"10.1016\/j.prp.2024.155717_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc.2016.40","article-title":"Mechanisms of human lymphoid chromosomal translocations","volume":"16","author":"Lieber","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2024.155717_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41588-019-0568-7","article-title":"Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation","volume":"52","author":"Basak","year":"2020","journal-title":"Nat. Genet"},{"issue":"12","key":"10.1016\/j.prp.2024.155717_bib25","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood.V98.12.3413","article-title":"The BCL11 gene family: involvement of BCL11A in lymphoid malignancies","volume":"98","author":"Satterwhite","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.prp.2024.155717_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fonc.2020.00375","article-title":"BCL11A promotes the progression of laryngeal squamous cell carcinoma","volume":"10","author":"Zhou","year":"2020","journal-title":"Front Oncol."},{"issue":"6155","key":"10.1016\/j.prp.2024.155717_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1126\/science.1242088","article-title":"An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level","volume":"342","author":"Bauer","year":"2013","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.prp.2024.155717_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1349-7006.2006.00209.x","article-title":"Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma","volume":"97","author":"Fukuhara","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2024.155717_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121607","article-title":"Double-drug loading upconversion nanoparticles for monitoring and therapy of a MYC\/BCL6-positive double-hit diffuse large B-cell lymphoma","volume":"287","author":"Yang","year":"2022","journal-title":"Biomaterials"},{"issue":"20","key":"10.1016\/j.prp.2024.155717_bib30","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasm","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.prp.2024.155717_bib31","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1200\/JCO.2010.31.8576","article-title":"TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression","volume":"29","author":"Jadersten","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2024.155717_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33230-3","article-title":"Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP","volume":"8","author":"Peroja","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155717_bib33","doi-asserted-by":"crossref","first-page":"10475","DOI":"10.2147\/OTT.S253758","article-title":"MDM2-P53 signaling pathway-mediated upregulation of CDC20 promotes progression of human diffuse large B-cell lymphoma","volume":"13","author":"Sun","year":"2020","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.prp.2024.155717_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/2040620721989579","article-title":"Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma","volume":"12","author":"Candelaria","year":"2021","journal-title":"Ther. Adv. Hematol."},{"issue":"8","key":"10.1016\/j.prp.2024.155717_bib35","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-09-1219","article-title":"Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494","volume":"16","author":"Winter","year":"2010","journal-title":"Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.prp.2024.155717_bib36","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1002\/ajh.26392","article-title":"Comprehensive analysis of TP53 mutation characteristics and identification of patients with inferior prognosis and enhanced immune escape in diffuse large B-cell lymphoma","volume":"97","author":"Zhang","year":"2022","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.prp.2024.155717_bib37","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/s41375-022-01634-w","article-title":"APR-246 triggers ferritinophagy and ferroptosis of diffuse large B-cell lymphoma cells with distinct TP53 mutations","volume":"36","author":"Hong","year":"2022","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.prp.2024.155717_bib38","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/S1470-2045(15)00005-4","article-title":"Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas","volume":"16","author":"Sarkozy","year":"2015","journal-title":"Lancet Oncol."},{"issue":"18","key":"10.1016\/j.prp.2024.155717_bib39","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","article-title":"Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d\u2032Etude des Lymphomes de l\u2032Adulte","volume":"23","author":"Feugier","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.prp.2024.155717_bib40","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.23.00033","article-title":"Differential efficacy from the addition of bortezomib to R-CHOP in diffuse large B-cell lymphoma according to the molecular subgroup in the REMoDL-B study with a 5-year follow-up","volume":"41","author":"Davies","year":"2023","journal-title":"J. Clin. Oncol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824006289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824006289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:25:20Z","timestamp":1778747120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824006289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":40,"alternative-id":["S0344033824006289"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155717","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCL11A expression worsens the prognosis of DLBCL and its co-expression with C-MYC predicts poor survival","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155717"}}